Endothelial microparticles and the antiangiogenic state in preeclampsia and the postpartum period

Am J Obstet Gynecol. 2012 Aug;207(2):140.e20-6. doi: 10.1016/j.ajog.2012.06.011. Epub 2012 Jun 11.

Abstract

Objective: We sought to determine if endothelial microparticles (EMPs), markers of endothelial damage, are associated with soluble fms-like tyrosine kinase 1 (sFlt1), soluble endoglin, and placental growth factor (PlGF) in women with preeclampsia.

Study design: A prospective cohort study was conducted on 20 preeclamptic women and 20 controls. EMPs by flow cytometry, sFlt1, soluble endoglin, and PlGF were measured at time of enrollment, 48-hours postpartum, and 1-week postpartum.

Results: Preeclamptic CD31(+)/42(-), CD62E(+), and CD105(+) EMP levels were significantly elevated in preeclamptics vs controls at time of enrollment. The sFlt1:PlGF ratio was correlated with CD31(+)/42(-) and CD105(+) EMPs (r = 0.69 and r = 0.51, respectively) in preeclampsia. Levels of CD31(+)/42(-) EMPs remained elevated 1-week postpartum (P = .026).

Conclusion: EMPs are elevated in preeclampsia. The correlation of EMPs and the sFlt1:PlGF ratio suggests that antiangiogenesis is related to apoptosis of the endothelia. Endothelial damage persists 1 week after delivery.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Antigens, CD / blood
  • Case-Control Studies
  • Cell-Derived Microparticles / physiology*
  • Endoglin
  • Endothelial Cells / physiology*
  • Female
  • Flow Cytometry
  • Humans
  • Placenta Growth Factor
  • Platelet Endothelial Cell Adhesion Molecule-1
  • Postpartum Period / blood*
  • Pre-Eclampsia / blood*
  • Pregnancy
  • Pregnancy Proteins / blood
  • Prospective Studies
  • Receptors, Cell Surface / blood
  • Vascular Endothelial Growth Factor Receptor-1 / blood

Substances

  • Antigens, CD
  • ENG protein, human
  • Endoglin
  • PGF protein, human
  • Platelet Endothelial Cell Adhesion Molecule-1
  • Pregnancy Proteins
  • Receptors, Cell Surface
  • Placenta Growth Factor
  • FLT1 protein, human
  • Vascular Endothelial Growth Factor Receptor-1